US Edition
News from boulder-monitor.com
Top Boulder-monitor.com News
Amgen · Thousand OaksAmgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday. The ongoing ASCEND study, which includes approximately 2,600 patients, is designed to evaluate the long-term safety and efficacy of rocatinlimab (150 mg and 300 mg) administered every four or eight weeks in individuals who completed a previ…See the Story
Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)
84% Center coverage: 13 sources
United States · United StatesSALINAS, Calif., Sept. 8, 2025 /PRNewswire/ -- Pacific Valley Bank (OTC: PVBK), a premier community bank serving California's Central Coast, proudly announces the appointment of Vida Villanueva as Executive Vice President and Chief Operating Officer. With nearly three decades of…See the Story
Pacific Valley Bank Appoints Vida Villanueva as Executive Vice President and Chief Operating Officer
87% Center coverage: 8 sources
